Arterial Stiffness as Surrogate End Point Needed Clinical Trials

被引：78

作者：

Laurent, Stephane ^{[1
]}

Briet, Marie

Boutouyrie, Pierre

机构：

[1] Univ Paris 05, Dept Pharmacol, F-75015 Paris, France

来源：

HYPERTENSION | 2012年 / 60卷 / 02期

关键词：

CONVERTING ENZYME-INHIBITION; EXPERT CONSENSUS DOCUMENT; CORONARY-HEART-DISEASE; LEFT-VENTRICULAR MASS; AORTIC STIFFNESS; CARDIOVASCULAR EVENTS; MULTIPLE BIOMARKERS; EUROPEAN-SOCIETY; RISK; PREDICTION;

D O I：

10.1161/HYPERTENSIONAHA.112.194456

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：518 / 522

页数：5

共 32 条

[1]

Ait-Oufella Hafid, 2010, J Hypertens, V28, P2336, DOI 10.1097/HJH.0b013e32833da2b2

[2] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

[3] PREDICTIVE VALUE OF PULSE WAVE VELOCITY FOR CARDIOVASCULAR EVENTS IN 15220 SUBJECTS: AN INDIVIDUAL PARTICIPANT META-ANALYSIS ON BEHALF OF THE PWV COLLABORATIVE GROUP [J].

Ben-Shlomo, Y. ;

McEniery, C. ;

Boutouyrie, P. ;

Cameron, J. ;

Chen, C. H. ;

Cruickshank, K. ;

Lakatta, E. ;

Laurent, S. ;

Maldonado, J. ;

Newman, A. ;

Ohishi, M. ;

Pannier, B. ;

Pereira, T. ;

Shokawa, T. ;

Sutton-Tyrell, K. ;

Webb, D. ;

Wilkinson, I. ;

Hansen, T. Willum ;

Zoungas, S. ;

Cockcroft, J. .

JOURNAL OF HYPERTENSION, 2010, 28 :E446-E446

[4] Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients - A longitudinal study [J].

Boutouyrie, P ;

Tropeano, AI ;

Asmar, R ;

Gautier, I ;

Benetos, A ;

Lacolley, P ;

Laurent, S .

HYPERTENSION, 2002, 39 (01) :10-15

[5] Pharmacological Modulation of Arterial Stiffness [J].

Boutouyrie, Pierre ;

Lacolley, Patrick ;

Briet, Marie ;

Regnault, Veronique ;

Stanton, Alice ;

Laurent, Stephane ;

Mahmud, Azra .

DRUGS, 2011, 71 (13) :1689-1701

[6] Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].

Conroy, RM ;

Pyörälä, K ;

Fitzgerald, AP ;

Sans, S ;

Menotti, A ;

De Backer, G ;

De Bacquer, D ;

Ducimetière, P ;

Jousilahti, P ;

Keil, U ;

Njolstad, I ;

Oganov, RG ;

Thomsen, T ;

Tunstall-Pedoe, H ;

Tverdal, A ;

Wedel, H ;

Whincup, P ;

Wilhelmsen, L ;

Graham, IM .

EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003

[7] Prognostic significance of left ventricular mass change during treatment of hypertension [J].

Devereux, RB ;

Wachtell, K ;

Gerdts, E ;

Boman, K ;

Nieminen, MS ;

Papademetriou, V ;

Rokkedal, J ;

Harris, K ;

Aurup, P ;

Dahlöf, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (19) :2350-2356

[8] Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease A Randomized Controlled Trial [J].

Edwards, Nicola C. ;

Steeds, Richard P. ;

Stewart, Paul M. ;

Ferro, Charles J. ;

Townend, Jonathan N. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (06) :505-512

[9]

Guerin AP, 2001, CIRCULATION, V103, P987

[10]

Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278

← 1 2 3 4 →